Philips advances quantitative MR

May 7, 2008 Philips advances quantitative MR Greg Freiherr -------------------------------------------------------------------------------- Quantitative MR, characterized by the precise measurement of data points that underlie MR images, may one day provide an exact and definable basis to recognize the early signs of disease and response to therapy. Philips Healthcare is moving toward that day, developing techniques that quantify the presence of cancerous tumors and heart disease. Stefanie Winkelmann, Ph.D., a Philips research scientist, explained how quantitative MR might be used to characterize tumor parameters such as vascular growth, hemodynamic changes in the response to treatments, and the permeability of vasculature. Similar signs of health might be seen in the heart through the quantification of scar tissue or plaque.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC